Black Rock Inc. Myriad Genetics Inc Transaction History
Black Rock Inc.
- $4.35 Trillion
- Q2 2024
A detailed history of Black Rock Inc. transactions in Myriad Genetics Inc stock. As of the latest transaction made, Black Rock Inc. holds 15,150,806 shares of MYGN stock, worth $397 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
15,150,806
Previous 14,879,319
1.82%
Holding current value
$397 Million
Previous $317 Million
16.82%
% of portfolio
0.01%
Previous 0.01%
Shares
13 transactions
Others Institutions Holding MYGN
# of Institutions
232Shares Held
92.6MCall Options Held
117KPut Options Held
113K-
Vanguard Group Inc Valley Forge, PA10.1MShares$264 Million0.0% of portfolio
-
Wellington Management Group LLP Boston, MA8.26MShares$217 Million0.04% of portfolio
-
Camber Capital Management LP Boston, MA5.5MShares$144 Million3.72% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny4.4MShares$115 Million0.05% of portfolio
-
State Street Corp Boston, MA4.34MShares$114 Million0.0% of portfolio
About MYRIAD GENETICS INC
- Ticker MYGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 80,634,800
- Market Cap $2.12B
- Description
- Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...